IGM Biosciences Inc (IGMS)
9.18
-0.11
(-1.18%)
USD |
NASDAQ |
May 17, 16:00
9.18
0.00 (0.00%)
After-Hours: 20:00
IGM Biosciences Market Cap: 544.20M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 544.20M |
| May 16, 2024 | 548.33M |
| May 15, 2024 | 560.13M |
| May 14, 2024 | 543.02M |
| May 13, 2024 | 547.15M |
| May 10, 2024 | 551.28M |
| May 09, 2024 | 597.32M |
| May 08, 2024 | 551.28M |
| May 07, 2024 | 586.10M |
| May 06, 2024 | 592.01M |
| May 03, 2024 | 594.37M |
| May 02, 2024 | 556.59M |
| May 01, 2024 | 559.54M |
| April 30, 2024 | 567.72M |
| April 29, 2024 | 571.85M |
| April 26, 2024 | 554.16M |
| April 25, 2024 | 450.99M |
| April 24, 2024 | 469.27M |
| April 23, 2024 | 453.94M |
| April 22, 2024 | 397.93M |
| April 19, 2024 | 424.46M |
| April 18, 2024 | 436.84M |
| April 17, 2024 | 479.29M |
| April 16, 2024 | 542.37M |
| April 15, 2024 | 554.75M |
| Date | Value |
|---|---|
| April 12, 2024 | 539.99M |
| April 11, 2024 | 492.83M |
| April 10, 2024 | 482.22M |
| April 09, 2024 | 515.23M |
| April 08, 2024 | 516.41M |
| April 05, 2024 | 516.41M |
| April 04, 2024 | 524.07M |
| April 03, 2024 | 532.33M |
| April 02, 2024 | 538.81M |
| April 01, 2024 | 557.09M |
| March 28, 2024 | 567.29M |
| March 27, 2024 | 544.95M |
| March 26, 2024 | 510.27M |
| March 25, 2024 | 512.03M |
| March 22, 2024 | 604.91M |
| March 21, 2024 | 601.39M |
| March 20, 2024 | 579.64M |
| March 19, 2024 | 583.16M |
| March 18, 2024 | 613.73M |
| March 15, 2024 | 625.49M |
| March 14, 2024 | 599.62M |
| March 13, 2024 | 584.93M |
| March 12, 2024 | 584.93M |
| March 11, 2024 | 614.32M |
| March 08, 2024 | 735.42M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
230.04M
Minimum
Oct 31 2023
3.876B
Maximum
Feb 09 2021
1.268B
Average
906.88M
Median
Sep 08 2022
Market Cap Benchmarks
| Akoya Biosciences Inc | 140.75M |
| Xilio Therapeutics Inc | 42.08M |
| NovaBay Pharmaceuticals Inc | 4.487M |
| Palatin Technologies Inc | 32.27M |
| iBio Inc | 6.899M |
Market Cap Related Metrics
| PS Ratio | 246.08 |
| Price to Book Value | 3.375 |
| Price | 9.18 |
| Earnings Yield | -46.42% |